Cas 59277-89-3 Acyclovir API Viral DNA Polymerase Inhibitor Polynucleotide Powder For Injection

Basic Information
Place of Origin: China
Minimum Order Quantity: Negotiation
Price: Negotiation
Packaging Details: Your demand
Delivery Time: Negotiation
Payment Terms: D/P, D/A, L/C, T/T
Supply Ability: Negotiation
Cas No: 59277-89-3 Ec No: 261-685-1
Name: Acyclovir Synonyms: Acycloguanosine; 9-[(2-Hydroxyethoxy)methyl]guanine
Molecular Formula: C8H11N5O3 Molecular Weight: 225.2
Melting Point: 256-257°C Boiling Point: 366.71°C
Solubility: H2O: 0.7 Mg/mL Density: 1.3654 G/cm3
Safety Description: S22-24/25-36-26-23 Risk Codes: R36/37/38-40-20/21/22
High Light:

59277-89-3 Acyclovir Polymerase Polynucleotide


Acyclovir Polymerase Polynucleotide 59277-89-3


Acyclovir Polymerase Polynucleotide 59277-89-3 cas

Acyclovir Cas No 59277-89-3 API; Polynucleotide


Name Acyclovir
Synonyms Acycloguanosine; 9-[(2-Hydroxyethoxy)methyl]guanine
Molecular Formula C8H11N5O3
Molecular Weight 225.2
CAS Registry Number 59277-89-3
EINECS Number 261-685-1
Melting point 256-257°C
Boiling point 366.71°C
Solubility H2O: 0.7 mg/mL
Density 1.3654 g/cm3
Safety Description S22-24/25-36-26-23
Risk Codes R36/37/38-40-20/21/22



Product Description:


Acyclovir, a synthetic purine nucleoside antiviral drug, contains purine nuclear compounds that are converted into triphosphates in the body, interfere with the viral DNA polymerase, and inhibit the replication of viral DNA to exert antiviral effects. Strong effect on the virus. It is one of the most used antiviral drugs, mainly for various infections caused by herpes simplex virus. It can be used in patients with initial or recurrent cutaneous, mucosal, external genital infections and in those with immunodeficiency. As the drug of choice for the treatment of HSV encephalitis, both the reduction of morbidity and the reduction of mortality are better than those achieved with adenosine arabinoside. It is also used for herpes zoster, Epstein Barr virus, and, in those with immunodeficiency, complicated by varicella and other infections. Topical is used only in the skin with less dermal absorption.


Product Use:


A broad-spectrum antiviral drug containing a purine nuclear compound converted in the body to a triphosphate compound that interferes with viral DNA polymerase and inhibits viral DNA replication to act as a Chemicalbook. It has strong effect on the virus. For the prevention and treatment of viral skin or mucous membrane infection, but also for hepatitis B, herpes simplex keratitis, varicella zoster virus infection.


Cas 59277-89-3 Acyclovir API Viral DNA Polymerase Inhibitor Polynucleotide Powder For Injection 0Cas 59277-89-3 Acyclovir API Viral DNA Polymerase Inhibitor Polynucleotide Powder For Injection 1

Product Catalogue:

Number Cas Name
1 61336-70-7 Amoxicillin Trihydrate
2 7177-48-2 Ampicillin Trihydrate
3 79350-37-1 Cefixime
4 92665-29-7 Cefprozil
5 91832-40-5 Cefdinir
6 64485-93-4 Cefotaxime Sodium
7 74578-69-1 Ceftriaxone Sodium
8 15686-71-2 Cephalexin
9 53994-73-3 Cefaclor
10 35607-66-0 Cefoxitin
11 55268-75-2 Cefuroxime
12 86393-32-0 Ciprofloxacin Hydrochloride
13 93106-60-6 Enrofloxacin
14 112811-59-3 Gatifloxacin
15 100986-85-42 Levofloxacin
16 138199-71-0 Levofloxacin Hydrochloride
17 115550-35-1 Marbofloxacin
18 124858-35-1 Nadifloxacin
19 82419-36-1 Ofloxacin
20 136905-87-8 Pazufloxacin mesilate
21 108138-46-1 Tosufloxacin
22 83905-01-5 Azithromycin
23 56-75-7 Chloramphenicol
24 81103-11-9 Clarithromycin
25 61177-45-5 Clavulanate Potassium
26 21462-39-5 Clindamycin Hydrochloride
27 24729-96-2 Clindamycin Phosphate
28 24390-14-5 Doxycycline Hydrochloride
29 1264-62-6 Erythromycin Ethylsuccinate
30 1405-41-0 Gentamycin Sulfate
31 126-07-8 Griseofulvin
32 7179-49-9 Lincomycin Hydrochloride
33 165800-03-3 Linezolid
34 96036-03-2 Meropenem
35 443-48-1 Metronidazole
36 1405-10-3 Neomycin Sulfate
37 2058-46-0 Oxytetracycline Hydrochloride
38 69388-84-7 Sulbactam Sodium
39 68-35-9 Sulfadiazine
40 547-32-0 Sulfadiazine Sodium
41 57-68-1 Sulfamethazine
42 3810-74-0 Streptomycin Sulfate
43 738-70-5 Trimethoprim (TMP)
44 64-75-5 Tetracycline Hydrochloride
45 89785-84-2 Tazobactam Sodium
46 61036-62-2 Teicoplanin
47 1404-93-94 Vancomycin Hydrochloride


About us



Zhejiang chemical import and export co., LTD. (zhejiang), formerly known as zhejiang branch of China national chemical import and export corporation, was established in December 1980. In 1988, he was transferred from Sinochem Corporation to be in charge of Zhejiang Provincial Department of Commerce and was renamed Zhejiang Chemical Import and Export Company. In 2003, the company changed its name to Zhejiang Chemical Import and Export Co., Ltd after the reform of state-owned enterprise shareholding system.

In 2008, it was incorporated into Zhejiang International Trade Group (one of the top 500 enterprises in China) and became the core member of the group's business circulation sector. The registered capital of the company is 72.5 million yuan, of which 38% are owned by the state and 62% are owned by employees.
There are 195 employees in the company, more than 79% of whom have bachelor's degree, 36% of whom are graduate students, and more than 90% of the salesmen have pharmaceutical and chemical background. The company is mainly engaged in the import and export trade of pharmaceutical raw materials and intermediates, dyes, pesticides, basic chemicals, fine chemicals, food and feed additives, pharmaceutical preparations and other products. The company has established close economic and trade relations with more than 100 countries and regions around the world. The company has wholly-owned subsidiaries Ruike International Trade Co., Ltd., Zhejiang Ruikai Chemical Co., Ltd., Zhejiang Fukai Import and Export Co., Ltd., joint-stock enterprise Zhejiang Aotokang Pharmaceutical Group Co., Ltd.
In recent years, especially since the establishment of the new team in 2019, the company has adhered to the development led by the party building, energized by reform, and improved efficiency by management. The company has shown a steady upward momentum of development. In 2020, the company achieved revenue of 3.337 billion yuan, total profit of 56.12 million yuan, total import and export of 450 million dollars.

In 2019, the company was rated as China Council for the Promotion of International Trade (CCPIT) Recommended Certification Enterprise, Top 100 International Pharmaceutical Enterprises -- a high-quality supplier and partner in the international market; In 2020, Zhejiang Provincial Department of Commerce and other units rated as the province's epidemic prevention and medical materials import outstanding contribution enterprise, Zhejiang Provincial Tax Bureau identified as the export tax rebate enterprises.


Contact Details
William Wang

Phone Number : +86-13588430486

WhatsApp : +8613588430486